purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. onsets van immuniteit zijn aangetoond een week na de primaire vaccinatiekuur voor rhinotracheitis, calicivirus, chlamydophila felis en panleucopenie componenten. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcp
boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.
nobivac forcat
intervet nederland b.v. - levend verzwakt chlamydophila felis, stam baker2,3 >= ie/ml; levend verzwakt feliene calicivirus stam f94,6 >= ie/ml; levend verzwakt feliene herpesvirus type 1, stam g2620a5,2 >= ie/ml; levend verzwakt feliene panleucopenievirus, stam mw-14,3 >= ie/ml; hulpstoffen; hulpstoffen:substantieconcentratie; dinatriumwaterstoffosfaat 2-water (e 339); gelatine (e 441); kaliumdiwaterstoffosfaat 0-water (e 340); saccharose; water voor injectie; - lyofilisaat voor suspensie voor injectie - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia vaccine
felocell cvr-c
elanco europe ltd. - levend verzwakt chlamydophila felis, stam baker; levend verzwakt feliene calicivirus stam f9; levend verzwakt feliene infectieuze rhinotracheÏteitsvirus, stam fvrm; levend verzwakt feliene panleucopenievirus, stam sneeuwluipaard - lyofilisaat voor suspensie voor injectie - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline calicivirus vaccine + chlamydia vaccine
avishield nd b1 lyofilisaat voor oculonasale suspensie/gebruik in drinkwater voor kippen
genera inc. - levend lentogeen verzwakt newcastle disease virus, stam hitchner b1 - lyofilisaat voor suspensie - newcastle disease virus / paramyxovirus - kippen
avishield nd lyofilisaat voor oculonasale suspensie/gebruik in drinkwater voor kippen en kalkoenen
genera inc. - levend lentogeen newcastle disease virus, stam la sota - lyofilisaat voor suspensie - newcastle disease virus / paramyxovirus - kalkoenen; kippen
avishield ib h120 lyofilisaat voor oculonasale suspensie/gebruik in drinkwater voor kippen
genera inc. - levend verzwakt aviaire infectieuze bronchitis virus, stam h120 - lyofilisaat voor suspensie - avian infectious bronchitis virus - kippen
poulvac ibmm+ark, lyofilisaat voor suspensie voor spraytoediening voor kippen
zoetis b.v. - levend infectieus aviair bronchitisvirus - lyofilisaat voor oculonasale suspensie - avian infectious bronchitis virus - kippen